Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Sale of product	$ 2,789,273	$ 2,617,514	$ 8,031,522	$ 7,369,922
Cost of product	1,305,730	1,006,334	3,470,706	3,009,656
Gross profit	1,483,543	1,611,180	4,560,816	4,360,266
Operating costs and expenses
Salaries and contract labor	800,550	650,065	2,535,771	1,944,013
General, administrative and consulting	1,008,219	885,807	2,784,367	2,667,535
Research and development	148,327	73,886	442,383	183,102
Total operating expenses	1,957,096	1,609,758	5,762,521	4,794,650
Net operating income (loss)	(473,553)	1,422	(1,201,705)	(434,384)
Other income (expense):
Other income	49,151	54,083	2,077,719	229,559
Interest income	2,849	14	3,574	95
Interest expense	(147,116)	(191,544)	(465,260)	(601,291)
Total other (expense) income	(95,116)	(137,447)	1,616,033	(371,637)
Net (loss) income	(568,669)	(136,025)	414,328	(806,021)
Less income attributable to noncontrolling interest		844		113,387
Net (loss) income attributable to International Isotopes Inc.	$ (568,669)	$ (136,869)	$ 414,328	$ (919,408)
Net loss per common share - basic:
Net loss per common share - diluted:
Weighted average common shares outstanding - basic:	514,789,680	494,635,990	509,587,202	469,627,961
Weighted average common shares outstanding - diluted:	514,789,680	494,635,990	511,057,330	469,627,961